FDA.reportPublic FDA data

acetaminophen 650 MG / caffeine 50 MG Oral Powder

RxCUI
1543072
RxNorm name
acetaminophen 650 MG / caffeine 50 MG Oral Powder
Term type
SCD
Status
Active
Updated
2026-10-17 23:57:04

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
082014
Active start
082014
Multiple ingredient
YES
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
acetaminophen650 MG / 1 EACHacetaminophenacetaminophen
caffeine50 MG / 1 EACHcaffeinecaffeine

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Oral Powder346289

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
acetaminophen161
caffeine1886

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
RXNAV_STRacetaminophen 650 MG / caffeine 50 MG Oral Powder1NAMES
RxNorm Nameacetaminophen 650 MG / caffeine 50 MG Oral Powder1NAMES
RxNorm SynonymAPAP 650 MG / Caffeine 50 MG Oral Powder1NAMES
TTYSCD1ATTRIBUTES
SPL_SET_IDe814cc43-ff68-4246-a386-3b3fa2be81791CODES
RxCUI15430721CODES

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 3 matching rows.

NDC11, Source, Active table
NDC11SourceActive
51596001101rxnav_ndcsyes
51596001001rxnav_historical
51596001110rxnav_historical

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
a5f925b6-2905-4264-ac53-c0a436328af0acetaminophen 650 MG / caffeine 50 MG Oral Powder [PSN] · acetaminophen 650 MG / caffeine 50 MG Oral Powder [SCD] · APAP 650 MG / Caffeine 50 MG Oral Powder [SY]31HEADACHE RELIEF TO-GO ™20140616
e814cc43-ff68-4246-a386-3b3fa2be8179acetaminophen 650 MG / caffeine 50 MG Oral Powder [PSN] · acetaminophen 650 MG / caffeine 50 MG Oral Powder [SCD] · APAP 650 MG / Caffeine 50 MG Oral Powder [SY]31Headache Relief To Go ™20140616

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
a5f925b6-2905-4264-ac53-c0a436328af0HEADACHE RELIEF TO-GO ™Breakthrough Products Inc.20140616
e814cc43-ff68-4246-a386-3b3fa2be8179Headache Relief To Go ™Breakthrough Products Inc.20140616

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCN02BEAnilidesATC1-4acetaminophen
ATCD11AXOther dermatologicalsATC1-4caffeine
ATCN06BCXanthine derivativesATC1-4caffeine
FDASPLD014970XanthinesCHEMhas_chemical_structurecaffeine
FDASPLN0000175739Central Nervous System StimulantEPChas_epccaffeine
FDASPLN0000175790MethylxanthineEPChas_epccaffeine
FDASPLN0000175729Central Nervous System StimulationPEhas_pecaffeine
MEDRTD000082AcetaminophenCHEMhas_ingredientacetaminophen
MEDRTD002110CaffeineCHEMhas_ingredientcaffeine
MEDRTD001049ApneaDISEASEmay_treatcaffeine
MEDRTD004342Drug HypersensitivityDISEASEci_withcaffeine
MEDRTD004342Drug HypersensitivityDISEASEci_withacetaminophen
MEDRTD005221FatigueDISEASEmay_treatcaffeine
MEDRTD005334FeverDISEASEmay_preventacetaminophen
MEDRTD005334FeverDISEASEmay_treatacetaminophen
MEDRTD005955Glucosephosphate Dehydrogenase DeficiencyDISEASEci_withacetaminophen
MEDRTD008107Liver DiseasesDISEASEci_withacetaminophen
MEDRTD010146PainDISEASEmay_preventacetaminophen
MEDRTD010146PainDISEASEmay_treatacetaminophen
MEDRTN0000000133Enzyme InhibitorsMOAhas_moacaffeine
MEDRTN0000000108Prostaglandin Receptor AntagonistsMOAhas_moaacetaminophen
MEDRTN0000008322BronchodilationPEhas_pecaffeine
MEDRTN0000008331Cardiovascular Activity AlterationPEhas_pecaffeine
MEDRTN0000175724Central Nervous System Activity AlterationPEhas_peacetaminophen
MEDRTN0000008567Decreased Collecting Duct Water PermeabilityPEhas_pecaffeine
MEDRTN0000008836Decreased Prostaglandin ProductionPEhas_peacetaminophen
MEDRTN0000009072Hypothalamic Endocrine Activity AlterationPEhas_peacetaminophen
MEDRTN0000009197Increased Central Nervous System Organized Electrical ActivityPEhas_pecaffeine
MEDRTN0000175725Peripheral Nervous System Activity AlterationPEhas_peacetaminophen
MEDRTN0000000026Hepatic MetabolismPKhas_pkacetaminophen
MEDRTN0000000042Renal ExcretionPKhas_pkacetaminophen

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH650 MG / 50 MG
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESRXNAV_HUMAN_DRUGUS
NAMESPrescribable Synonymacetaminophen 650 MG / caffeine 50 MG Oral Powder
SOURCESSourceMetathesaurus FDA Structured Product Labels